CanAssist Breast Impacting Clinical Treatment Decisions in Early-Stage HR+ Breast Cancer Patients: Indian Scenario

CanAssist Breast (CAB) has thus far been validated on a retrospective cohort of 1123 patients who are mostly Indians. Distant metastasis–free survival (DMFS) of more than 95% was observed with significant separation (P < 0.0001) between low-risk and high-risk groups. In this study, we demonstrate...

Descripción completa

Detalles Bibliográficos
Autores principales: Sankaran, Satish, Dikshit, Jyoti Bajpai, Prakash SV, Chandra, Mallikarjuna, SE, Somashekhar, SP, Patil, Shekhar, Kumar, Rajeev, Prasad, Krishna, Shet, Dinesh, Bakre, Manjiri M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer India 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119549/
https://www.ncbi.nlm.nih.gov/pubmed/33994724
http://dx.doi.org/10.1007/s13193-019-01014-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119549/
https://www.ncbi.nlm.nih.gov/pubmed/33994724
http://dx.doi.org/10.1007/s13193-019-01014-4

Ejemplares similares